Medplus Health Services Limited held its 20th Annual General Meeting (AGM) on August 17, 2026, to transact ordinary and special business items. The meeting was conducted via Video Conferencing (VC) / Other Audio Visual Means (OAVM) in compliance with Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI) regulations.

Shareholders approved the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. Statutory auditors B S R and Co and secretarial auditors R & A Associates issued unqualified opinions on the financial statements and matters bearing material impact on the company’s functioning.

Key Resolutions Passed

The AGM addressed several critical governance and operational resolutions:

• Financial Approval: Adoption of audited financial statements for FY26 along with reports from the Board of Directors and Auditors.
• Director Re-appointments: Dr. Cherukupalli Bhaskar Reddy was re-appointed as Whole Time Director after retiring by rotation. Gangadi Madhukar Reddy was re-appointed as Managing Director & CEO.
• Independent Director Appointments: Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar were appointed as Independent Directors.
• Cost Auditor Ratification: Remuneration for M/s. M P R & Associates as Cost Auditors for FY27 was ratified.

Meeting Proceedings

Gangadi Madhukar Reddy, Chairman & Managing Director and CEO, chaired the proceedings which commenced at 3:30 pm and concluded at 4:47 pm. A total of 134 members attended the virtual meeting. The quorum was present at the start, enabling the transaction of all agenda items.

Ms. Rashida Adenwala of R & A Associates served as the Scrutinizer for the voting process. Remote e-voting was open from August 14, 2026, to August 16, 2026. Members present who had not voted remotely could cast votes via Insta Poll during the meeting. The consolidated voting results will be submitted to stock exchanges within prescribed timelines.

MedPlus Health Services recorded a significant block trade on the BSE, with the transaction valued at ₹60.69 crore. The deal involved approximately 869419 shares executed at a price of ₹698.00 per share, marking a notable large-scale transaction on the exchange.

Block Trade Details

The following table summarizes the key parameters of the block trade:

Block trades of this scale typically involve institutional participants and are executed as a single, large transaction on the exchange. The trade in MedPlus Health Services represents a substantial movement of shares at a fixed price of ₹698.00, aggregating to a total consideration of ₹60.69 crore.